Project Ipsilon - taking cognitive vitals - one musical note at a time.
Music Activity, Data and Artificial Intelligence = Window to Cognitive Health.
Music, notably piano playing, involves multiple sensory processing, comprehension, quasi-simultaneous decision making and action execution. Simply put, it is one of the best ways to evaluate brain functions and to train minds.
Our Products:
1) Ipsilon Cognitive Test - "The Cognitive Vitals"
Web-based computerized cognitive assessment aid, used on tablet. Expected launch in 3Q 2020 in EU as medical device certification class 1 device (software as medical device).
Fast, accurate, game-like cognitive checkup which fits to clinical workflow.
Suitable for assessing pre-clinical, early dementia, and MCI (mild cognitive impairment) often caused by chronic illnesses.
Operable by non-specialist, 3-5 min tablet checkup gives immediate cognitive functionality overview.
Features:
What it does: evaluate executive function, inhibition control, attention, memory function by quantifying learning to assess brain functionalities.
What inputs/ outputs it assesses: comprehension (visuo-spatial/motor encoding) and time-stamped finger responses.
What advantage?: eliminates language biases. Elicit multi-sensory responses, monitoring capability of many brain regions and functionalities.
What value proposition?: compatible to research-grade cognitive batteries, can be combined with EEG and eye tracking. Can be used as dementia prevention tool.
Product availability: as an web-based app (software as service) for tablets, by subscription.
Intended customers: healthcare providers.
2) Dementia Risk Assessment
Ipsilon's artificial neural network tool to analyze the collected data and detect mild cognitive impairment (MCI) and early dementia among risk groups.
Features:
What it does: detect cognitive abnormalities associated with MCI and early dementia, calculates likelihood of developing dementia.
What data does it use?: Ipsilon Test collects user response data and our algorithm analyzes the data and determine likelihood of developing dementia.
What advantage?: MCI and early dementia are hard to detect. Music playing reveals slightest cognitive abnormalities.
What purpose?: To create personal baseline, enable early detection, providing access to early intervention to delay onset and/or preserve cognitive functionalities.
Side effects?: No. Non-invasive.
Targeted conditions:
Mild Cognitive Impairment (MCI) and vascular dementia; Alzheimer's Disease; Alzheimer's Disease Related Dementia
Targeted customers:
Healthcare providers
Assisted living facilities
Vertical industries:
Insurance: elderly cognitive fitness for driving
Financial institutions: assessing elderly's asset management decision-making capabilities
3) Consultancy over implementing know-how of music to optimize cognitive performances available.
-please inquire us through Contact Us.
-example of applicable domains: ADHD attention remedy, athletic training, public speaking, simulated performance training for corporate groups
Our One Pager and Investor Deck are available upon request.
One-pager can be seen at Slideshare of Yayoi Sakaki, Founder and inventor.
Patend pending with our methodologies.
We are/ have been mentored through incubators/accelerator at:
InnoLabs 2nd Open Call Accelerator through delivering partner, Norway Health Tech, November, 2018 to August, 2019)
HighTechXL accelerator, Eindhoven, The Netherlands (http://www.hightechxl.com/), September 4 to December 6, 2017
ENDuRE Project (University of Pisa, www.endureproject.eu/), May 30, 2016 to June 11, 2016
Erasmus Center for Entrepreneurship (http://ece.nl/), May 6, 2016 to July 1, 2016
key words: aging, Alzheimer's, dementia, MCI, executive function, mental performance, brainwaves, music, piano, digital therapy, sensory stimulation, cognition, cognitive wellness, mindfulness.